Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers.
D000526:Alprenolol / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001812:Blood-Brain Barrier; D002415:Cats; D003864:Depression, Chemical; D005260:Female; D005268:Femoral Vein; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007536:Isomerism; D008297:Male; D011433:Propranolol / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology; D014711:Vertebral Artery; D015016:Yohimbine / Q000494:pharmacology
D013565:Sympatholytics; D015016:Yohimbine; D000526:Alprenolol; D011433:Propranolol